Turnstone, once allied with AbbVie and Takeda, accepts $8M Xoma buyout
Turnstone Biologics has limped to the exit. Xoma Royalty is buying Turnstone for less than $8 million, marking a low-profile end for a company that pulled in hundreds of millions of dollars from investors and partners.
Turnstone Biologics has limped to the exit. Xoma Royalty is buying Turnstone for less than $8 million, marking a low-profile end for a company that pulled in hundreds of millions of dollars from investors and partners.
